Barely Significant
← all excerpts

Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR<sup>+</sup>HER2<sup>-</sup> Advanced Breast Cancer.

Cancer Manag Res · 2026 · PMC13207859 · PMID 42205896

Europe PMCDOI
1
hedged sentence
0.3930
closest p · 7.9× alpha
0.3930
boldest claim

The sentences

showed a trendP = 0.393not close (p > 0.1)
However, in the multivariate model, only ER level emerged as an independent protective factor, while liver metastasis showed a trend toward being a risk factor without reaching statistical significance (P = 0.393).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.